Copyright
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Nov 6, 2019; 7(21): 3569-3574
Published online Nov 6, 2019. doi: 10.12998/wjcc.v7.i21.3569
Published online Nov 6, 2019. doi: 10.12998/wjcc.v7.i21.3569
Liver transplantation for severe portopulmonary hypertension: A case report and literature review
Xiao-Jie Chen, Zhi-Jun Zhu, Li-Ying Sun, Lin Wei, Zhi-Gui Zeng, Ying Liu, Wei Qu, Liang Zhang, Liver Transplantation Center, National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
Zhi-Jun Zhu, Li-Ying Sun, Clinical Center for Pediatric Liver Transplantation, Capital Medical University, Beijing 100050, China
Zhi-Jun Zhu, Li-Ying Sun, Beijing Key Laboratory of Tolerance Induction and Organ Protection in Transplantation, Beijing 100050, China
Li-Ying Sun, Department of Intensive Care Unit, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
Author contributions: All authors equally contributed to this paper.
Supported by Beijing Science and Technology Commission Capital Clinical Application Research , No. Z181100001718220 .
Informed consent statement: The patient provided informed verbal consent prior to study enrollment.
Conflict-of-interest statement: In relation to this report, I declare that there are no conflicts of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Zhi-Jun Zhu, MD, PhD, Chief Doctor, Professor, Liver Transplantation Center, National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, 95 Yong-an Road, Xi-Cheng District, Beijing 100050, China. zhu-zhijun@outlook.com
Telephone: +86-18601253456 Fax: +86-10-63139335
Received: July 22, 2019
Peer-review started: July 23, 2019
First decision: July 31, 2019
Revised: September 1, 2019
Accepted: September 11, 2019
Article in press: September 11, 2019
Published online: November 6, 2019
Processing time: 108 Days and 13.2 Hours
Peer-review started: July 23, 2019
First decision: July 31, 2019
Revised: September 1, 2019
Accepted: September 11, 2019
Article in press: September 11, 2019
Published online: November 6, 2019
Processing time: 108 Days and 13.2 Hours
Core Tip
Core tip: Peri-operative pharmacotherapy was administered to a patient with portopulmonary hypertension (PoPH) to reduce pulmonary pressure in order to ensure the safety of liver transplantation (LT). LT may eventually cure severe PoPH.